UOC
ROIV icon

UBS O'Connor’s Roivant Sciences ROIV Stock Holding History

UBS O'Connor’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-42,819
Closed -$432K – 445
2025
Q1 		$432K Sell
42,819
-136,447
-76% -$1.48M 0.01% 225
2024
Q4 		$2.12M Buy
179,266
+32,329
+22% +$382K 0.05% 148
2024
Q3 		$1.7M Buy
146,937
+22,720
+18% +$259K 0.04% 198
2024
Q2 		$1.31M Buy
124,217
+27,000
+28% +$296K 0.04% 258
2024
Q1 		$1.02M Sell
97,217
-101,215
-51% -$1.09M 0.03% 272
2023
Q4 		$2.23M Buy
198,432
+34,221
+21% +$334K 0.07% 157
2023
Q3 		$1.92M Sell
164,211
-26,000
-14% -$294K 0.03% 251
2023
Q2 		$1.92M Buy
190,211
+28,386
+18% +$254K 0.04% 303
2023
Q1 		$1.19M Buy
+161,825
New +$1.33M 0.03% 388

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return